Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Aug;10(4):561-563.
doi: 10.21037/hbsn-21-178.

Neuroendocrine liver metastases treatment strategies: a viewpoint

Affiliations
Editorial

Neuroendocrine liver metastases treatment strategies: a viewpoint

Roberta Elisa Rossi. Hepatobiliary Surg Nutr. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/hbsn-21-178). The author has no conflicts of interest to declare.

Comment on

References

    1. Cloyd JM, Ejaz A, Konda B, et al. Neuroendocrine liver metastases: a contemporary review of treatment strategies. Hepatobiliary Surg Nutr 2020;9:440-51. 10.21037/hbsn.2020.04.02 - DOI - PMC - PubMed
    1. Mazzaferro V, Sposito C, Coppa J, et al. The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors. Am J Transplant 2016;16:2892-902. 10.1111/ajt.13831 - DOI - PubMed
    1. Ruzzenente A, Bagante F, Bertuzzo F, et al. Liver resection for neuroendocrine tumor liver metastases within Milan criteria for liver transplantation. J Gastrointest Surg 2019;23:93-100. 10.1007/s11605-018-3973-9 - DOI - PubMed
    1. Sposito C, Rossi RE, Monteleone M, et al. Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors. Transplantation 2021. [Epub ahead of print]. doi: .10.1097/TP.0000000000003802 - DOI - PubMed
    1. Merola E, Falconi M, Rinke A, et al. Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3. Am J Surg 2020;220:284-9. 10.1016/j.amjsurg.2020.03.009 - DOI - PubMed